首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi

市場調查報告書

商品編碼

1401820

反義和 RNAI 治療市場，按技術、按應用、按給藥途徑、按國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Antisense & RNAI Therapeutics Market, By Technology, By Application, By Route of Administration, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日期: 2024年01月01日 | 出版商:

AnalystView Market Insights | 英文 316 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

報告要點

2022 年反義和 RNAI 治療市場規模為 38 億美元，2023 年至 2030 年CAGR為 19.1%。

反義和RNAI治療市場-市場動態

反義和 RNAi 療法在治療罕見疾病方面的變革性影響，推動市場需求

推動市場的主要因素是反義和 RNAi 療法在治療罕見疾病方面的變革性影響。透過採用基因沉默，這些療法可以防止疾病相關蛋白質的產生，特別有利於脊髓性肌肉萎縮症和雜合子家族性高膽固醇血症等疾病。 RNAi 治療以致病 mRNA 為目標，其精確性和選擇性使其成為罕見疾病的先進且受歡迎的治療方法。 RNAi 療法需求的激增是一個關鍵促進因素，再加上研發投資的增加和有前景的管道產品，共同推動了市場擴張。

反義和 RNAI 治療市場 - 關鍵見解

根據我們的研究分析師分享的分析，預計全球市場在預測期內（2023-2030 年）每年將以 19.1% 左右的CAGR成長

基於技術細分，預計反義RNA將在2022年顯示最大的市場佔有率

依給藥途徑細分，2022年遺傳疾病為主導類型

按地區分類，北美是 2022 年的主要收入來源

反義和RNAI治療市場-細分分析：

全球反義和 RNAI 治療市場根據技術、應用、給藥途徑和地區進行細分。

市場依技術分為兩類：RNA干擾和反義RNA。 2022年，反義RNA部門佔了最大的收入佔有率。該部門主要在創收方面處於領先地位，並且正在積極進行管理各種條件的試驗。該技術用於調節蛋白質和基因表達，在心血管、呼吸系統、神經退化性疾病和遺傳性疾病方面具有廣泛的應用，預計將出現顯著的細分市場成長。例如，麻省大學陳醫學院於 2021 年 12 月進行的一項臨床試驗證明，使用反義寡核苷酸可以安全抑制突變型肌萎縮側索硬化症 (ALS) 基因。

根據給藥途徑，市場分為九類：遺傳疾病、癌症、傳染病、神經退化性疾病、心臟代謝和腎臟疾病、眼部疾病、呼吸系統疾病、皮膚疾病等。 2022 年，遺傳性疾病領域的收入佔有率最高。控制杜氏肌肉營養不良症 (DMD) 和脊髓性肌肉萎縮症等疾病的需求日益成長，預計將推動寡核苷酸產品的使用。寡核苷酸藥物領域的研究工作正在迅速擴大，這從越來越多的研究中可以看出。公司正在尋求監管部門批准用於治療遺傳疾病的產品。例如，2019 年 12 月，針對 DMD 患者的反義寡核苷酸療法 golodirsen 獲得了美國食品藥物管理局 (FDA) 的批准。

反義和 RNAI 治療市場 - 地理洞察

從地理來看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。

反義與RNAI治療市場-競爭格局：

在反義和 RNAi 治療市場中，公司部署各種關鍵策略來鞏固自己的地位。他們優先考慮廣泛的研究和開發，投資尖端技術以找出精確的基因標靶並創造有效的治療分子。管道多元化仍然是首要任務，旨在涵蓋多種疾病並擴大市場範圍。與研究機構和行業同行的合作夥伴關係可加快進展並促進資源共享。同時，公司確保嚴格遵守監管標準，並有效完成核准流程。批准後的策略商業化計劃，包括有針對性的行銷和無障礙舉措，對於成功採用至關重要。此外，遞送系統的持續進步是最佳化治療效果的關鍵焦點。這些綜合策略共同推動了醫療保健領域反義和 RNAi 療法的進步和接受。公司透過專門的進步利用反義和 RNAi 技術。

介紹
- 按地理位置分類的細分市場佔有率分析
北美洲
- 概述
- 北美反義和 RNAI 療法主要製造商
- 北美市場規模和預測（按國家）
- 北美市場規模和預測（按技術）
- 北美市場規模和預測（按應用）
- 北美市場規模與預測（按管理途徑）
- 美國
- 加拿大
歐洲
- 概述
- 歐洲反義和 RNAI 療法主要製造商
- 歐洲市場規模和預測（按國家）
- 歐洲市場規模與預測（按技術）
- 歐洲市場規模和預測（按應用）
- 歐洲市場規模與預測（按管理途徑）
- 德國
- 義大利
- 英國
- 法國
- 俄羅斯
- 荷蘭
- 瑞典
- 波蘭
- 歐洲其他地區
亞太地區 (APAC)
- 概述
- 亞太地區反義和 RNAI 療法主要製造商
- 亞太地區市場規模與預測（按國家）
- 亞太地區市場規模與預測（按技術）
- 亞太地區市場規模與預測（按應用）
- 亞太地區市場規模與預測（依管理途徑）
- 印度
- 中國
- 日本
- 韓國
- 澳洲
- 泰國
- 印尼
- 菲律賓
- 亞太地區其他地區
拉丁美洲
- 概述
- 拉丁美洲反義和 RNAI 療法主要製造商
- 拉丁美洲市場規模與預測（按國家）
- 拉丁美洲市場規模與預測（按技術）
- 拉丁美洲市場規模與預測（按應用）
- 拉丁美洲市場規模與預測（按管理途徑）
- 巴西
- 墨西哥
- 阿根廷
- 哥倫比亞
- 拉丁美洲其他地區
中東和非洲
- 概述
- 中東和非洲反義和RNAI療法主要製造商
- 中東和非洲市場規模及預測（按國家）
- 中東和非洲市場規模及預測（按技術）
- 中東和非洲市場規模及預測（按應用）
- 中東和非洲市場規模及預測（按管理途徑）
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 以色列
- 土耳其
- 阿爾及利亞
- 埃及
- MEA 的其餘部分

第 11 章：主要供應商分析 - 反義與 RNAI 治療產業

競爭儀表板
公司簡介
- GSK plc
- Olix Pharmaceuticals, Inc.
- Sanofi
- Alnylam Pharmaceuticals, Inc.
- Arbutus Biopharma
- Benitec Biopharma Inc.
- Silence Therapeutics
- Ionis Pharmaceuticals, Inc
- Bio-Path Holdings Inc.
- Antisense Therapeutics Limited.
- Others

第 12 章：360 度分析師視角

第 13 章：附錄

研究方法論
參考
縮寫
免責聲明
聯絡我們

簡介目錄圖表

Product Code: ANV2006

REPORT HIGHLIGHT

Antisense & RNAI Therapeutics Market size was valued at USD 3,800 Million in 2022, expanding at a CAGR of 19.1% from 2023 to 2030.

Antisense technology, acknowledged for gene expression manipulation, stands as a successful treatment avenue for numerous medical conditions. The use of Antisense and RNAi therapies for rare diseases has notably improved therapeutic outcomes. For example, Antisense Oligonucleotides (ASOs) have gained approval for treating rare neurological conditions such as Duchenne muscular dystrophy (DMD) and spinal muscular atrophy (SMA), signaling anticipated growth in the upcoming years. Additionally, augmented R&D funding and a robust product pipeline are expected to drive market expansion. For instance, in January 2023, Agilent invested USD 725 million in expanding manufacturing capabilities for nucleic acid-based therapeutics, including antisense therapies. The scarcity of global treatment options for rare diseases has spurred increased funding and research endeavors focused on developing novel treatments for these conditions.

Antisense & RNAI Therapeutics Market- Market Dynamics

Transformative impact of antisense and RNAi therapeutics in treating rare diseases to propel market demand

The primary factors driving the market are the transformative impact of antisense and RNAi therapeutics in treating rare diseases. By employing gene silencing, these therapies prevent the production of disease-related proteins, notably benefiting conditions like spinal muscular atrophy and heterozygous familial hypercholesterolemia. The precision and selectivity of RNAi treatments, which target disease-causing mRNA, position them as advanced and favored treatments for rare ailments. This surge in demand for RNAi therapeutics acts as a key driver, complemented by increased R&D investment and promising pipeline products, collectively propelling market expansion.

Antisense & RNAI Therapeutics Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 19.1% over the forecast period (2023-2030)

Based on Technology segmentation, antisense RNA was predicted to show maximum market share in the year 2022

Based on Route of Administration segmentation, genetic disease was the leading type in 2022

On the basis of region, North America was the leading revenue generator in 2022

Antisense & RNAI Therapeutics Market- Segmentation Analysis:

The Global Antisense & RNAI Therapeutics Market is segmented on the basis of Technology, Application, Route of Administration, and Region.

The market is divided into two categories based on Technology: RNA Interference and Antisense RNA. In 2022, the antisense RNA division represented the largest share of revenue. This segment has predominantly led in revenue generation and is actively undergoing trials for managing various conditions. Utilized for regulating both protein and gene expression, this technology exhibits broad applications across cardiovascular, respiratory, neurodegenerative, and genetic disorders, foreseeing significant segmental growth. For instance, a clinical trial at UMass Chan Medical School in December 2021 demonstrated the safe suppression of the mutant amyotrophic lateral sclerosis (ALS) gene using antisense oligonucleotides.

The market is divided into nine categories based on Route of Administration: Genetic Disease, Cancer, Infectious Disease, Neurodegenerative Disorders, Cardio Metabolic & Renal Disorders, Ocular Disorders, Respiratory Disorders, Skin Disorders and Others. The genetic disorder sector commanded the highest revenue share in 2022. The growing necessity to manage diseases like Duchenne muscular dystrophy (DMD) and spinal muscular atrophy is expected to drive the usage of oligonucleotide products. Research endeavors in the realm of oligonucleotide medications are rapidly expanding, evident from the increasing number of research studies. Companies are pursuing regulatory approvals for products designed to treat genetic diseases. For instance, in December 2019, golodirsen, an antisense oligonucleotide therapy for individuals afflicted with DMD, received approval from the Food and Drug Administration (FDA).

Antisense & RNAI Therapeutics Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Antisense & RNAI Therapeutics Market- Competitive Landscape:

In the Antisense & RNAi Therapeutics Market, companies deploy various key strategies to bolster their position. They prioritize extensive research and development, investing in cutting-edge technologies to pinpoint precise gene targets and create effective therapeutic molecules. Diversifying pipelines remains a top priority, aiming to encompass a wide array of diseases and broaden market reach. Collaborative partnerships with research institutions and industry counterparts expedite progress and facilitate resource sharing. Concurrently, companies ensure rigorous compliance with regulatory standards, efficiently navigating approval processes. Post-approval, strategic commercialization plans, inclusive of targeted marketing and accessibility initiatives, are vital for successful adoption. Furthermore, continuous advancements in delivery systems are a pivotal focus to optimize therapeutic efficacy. These comprehensive strategies collectively drive the progression and acceptance of antisense and RNAi therapies within the healthcare landscape. Companies capitalize on antisense & RNAi technologies through dedicated advancements.

Recent Developments:

In April 2020, Alnylam Pharmaceuticals, Inc. partnered with Blackstone, with Blackstone investing USD 2 billion to accelerate RNAi therapeutics advancement.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTISENSE & RNAI THERAPEUTICS MARKET KEY PLAYERS

GSK plc
Olix Pharmaceuticals, Inc.
Sanofi
Alnylam Pharmaceuticals, Inc.
Arbutus Biopharma
Benitec Biopharma Inc.
Silence Therapeutics
Ionis Pharmaceuticals, Inc
Bio-Path Holdings Inc.
Antisense Therapeutics Limited.
Others

GLOBAL ANTISENSE & RNAI THERAPEUTICS MARKET, BY TECHNOLOGY

RNA Interference
Antisense RNA

GLOBAL ANTISENSE & RNAI THERAPEUTICS MARKET, BY APPLICATION

Neurodegenerative Disorders
Cardio Metabolic & Renal Disorders
Genetic Disease
Cancer
Infectious Disease
Ocular Disorders
Respiratory Disorders
Skin Disorders
Others

GLOBAL ANTISENSE & RNAI THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION

Intravenous Injections
Intrathecal Injections
Subcutaneous Injections
Other Delivery Methods

GLOBAL ANTISENSE & RNAI THERAPEUTICS MARKET, BY REGION

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Antisense & RNAI Therapeutics Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Antisense & RNAI Therapeutics Market Snippet by Technology
- 2.1.2. Antisense & RNAI Therapeutics Market Snippet by Application
- 2.1.3. Antisense & RNAI Therapeutics Market Snippet by Route of Administration
- 2.1.4. Antisense & RNAI Therapeutics Market Snippet by Country
- 2.1.5. Antisense & RNAI Therapeutics Market Snippet by Region
2.2. Competitive Insights

3. Antisense & RNAI Therapeutics Key Market Trends

3.1. Antisense & RNAI Therapeutics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Antisense & RNAI Therapeutics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Antisense & RNAI Therapeutics Market Opportunities
3.4. Antisense & RNAI Therapeutics Market Future Trends

4. Antisense & RNAI Therapeutics Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Antisense & RNAI Therapeutics Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Antisense & RNAI Therapeutics Market Landscape

6.1. Antisense & RNAI Therapeutics Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Antisense & RNAI Therapeutics Market - By Technology

7.1. Overview
- 7.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
- 7.1.2. RNA Interference
- 7.1.3. Antisense RNA

8. Antisense & RNAI Therapeutics Market - By Application

8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
- 8.1.2. Genetic Disease
- 8.1.3. Cancer
- 8.1.4. Infectious Disease
- 8.1.5. Neurodegenerative Disorders
- 8.1.6. Cardio Metabolic & Renal Disorders
- 8.1.7. Ocular Disorders
- 8.1.8. Respiratory Disorders
- 8.1.9. Skin Disorders
- 8.1.10. Others

9. Antisense & RNAI Therapeutics Market - By Route of Administration

9.1. Overview
- 9.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
- 9.1.2. Intravenous Injections
- 9.1.3. Intrathecal Injections
- 9.1.4. Subcutaneous Injections
- 9.1.5. Other Delivery Methods

10. Antisense & RNAI Therapeutics Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Antisense & RNAI Therapeutics Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Antisense & RNAI Therapeutics Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Antisense & RNAI Therapeutics Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Antisense & RNAI Therapeutics Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Antisense & RNAI Therapeutics Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Antisense & RNAI Therapeutics Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. GSK plc
- 11.2.2. Olix Pharmaceuticals, Inc.
- 11.2.3. Sanofi
- 11.2.4. Alnylam Pharmaceuticals, Inc.
- 11.2.5. Arbutus Biopharma
- 11.2.6. Benitec Biopharma Inc.
- 11.2.7. Silence Therapeutics
- 11.2.8. Ionis Pharmaceuticals, Inc
- 11.2.9. Bio-Path Holdings Inc.
- 11.2.10. Antisense Therapeutics Limited.
- 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us

簡介目錄圖表

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Antisense & RNAI Therapeutics Market: Technology Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Technology
TABLE Global Antisense & RNAI Therapeutics Market, by Technology 2018-2030 (USD Million)
TABLE Antisense & RNAI Therapeutics Market: Application Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Antisense & RNAI Therapeutics Market, by Application 2018-2030 (USD Million)
TABLE Antisense & RNAI Therapeutics Market: Route of Administration Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Route of Administration
TABLE Global Antisense & RNAI Therapeutics Market, by Route of Administration 2018-2030 (USD Million)
TABLE Antisense & RNAI Therapeutics Market: Regional snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Antisense & RNAI Therapeutics Market, by Region 2018-2030 (USD Million)
TABLE North America Antisense & RNAI Therapeutics Market, by Country, 2018-2030 (USD Million)
TABLE North America Antisense & RNAI Therapeutics Market, by Technology, 2018-2030 (USD Million)
TABLE North America Antisense & RNAI Therapeutics Market, by Application, 2018-2030 (USD Million)
TABLE North America Antisense & RNAI Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
TABLE Europe Antisense & RNAI Therapeutics Market, by Country, 2018-2030 (USD Million)
TABLE Europe Antisense & RNAI Therapeutics Market, by Technology, 2018-2030 (USD Million)
TABLE Europe Antisense & RNAI Therapeutics Market, by Application, 2018-2030 (USD Million)
TABLE Europe Antisense & RNAI Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
TABLE Asia Pacific Antisense & RNAI Therapeutics Market, by Country, 2018-2030 (USD Million)
TABLE Asia Pacific Antisense & RNAI Therapeutics Market, by Technology, 2018-2030 (USD Million)
TABLE Asia Pacific Antisense & RNAI Therapeutics Market, by Application, 2018-2030 (USD Million)
TABLE Asia Pacific Antisense & RNAI Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
TABLE Latin America Antisense & RNAI Therapeutics Market, by Country, 2018-2030 (USD Million)
TABLE Latin America Antisense & RNAI Therapeutics Market, by Technology, 2018-2030 (USD Million)
TABLE Latin America Antisense & RNAI Therapeutics Market, by Application, 2018-2030 (USD Million)
TABLE Latin America Antisense & RNAI Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
TABLE Middle East and Africa Antisense & RNAI Therapeutics Market, by Country, 2018-2030 (USD Million)
TABLE Middle East and Africa Antisense & RNAI Therapeutics Market, by Technology, 2018-2030 (USD Million)
TABLE Middle East and Africa Antisense & RNAI Therapeutics Market, by Application, 2018-2030 (USD Million)
TABLE Middle East and Africa Antisense & RNAI Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)

List of Figures

FIGURE Antisense & RNAI Therapeutics Market Segmentation
FIGURE Market research methodology
FIGURE Value chain analysis
FIGURE Porter's Five Forces Analysis
FIGURE Market Attractiveness Analysis
FIGURE COVID-19 Impact Analysis
FIGURE Pre & Post COVID-19 Impact Comparision Study
FIGURE Competitive Landscape; Key company market share analysis, 2022
FIGURE Technology segment market share analysis, 2022 & 2030
FIGURE Technology segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Application segment market share analysis, 2022 & 2030
FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Route of Administration segment market share analysis, 2022 & 2030
FIGURE Route of Administration segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Regional segment market share analysis, 2022 & 2030
FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE North America Antisense & RNAI Therapeutics Market share and leading players, 2022
FIGURE Europe Antisense & RNAI Therapeutics Market share and leading players, 2022
FIGURE Asia Pacific Antisense & RNAI Therapeutics Market share and leading players, 2022
FIGURE Latin America Antisense & RNAI Therapeutics Market share and leading players, 2022
FIGURE Middle East and Africa Antisense & RNAI Therapeutics Market share and leading players, 2022
FIGURE North America market share analysis by country, 2022
FIGURE U.S. Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Canada Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Europe Antisense & RNAI Therapeutics Market share analysis by country, 2022
FIGURE Germany Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Spain Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Italy Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE France Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE UK Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Russia Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Netherlands Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Sweden Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Poland Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of the Europe Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Asia Pacific Antisense & RNAI Therapeutics Market share analysis by country, 2022
FIGURE India Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE China Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Japan Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE South Korea Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Australia Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Thailand Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Indonesia Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Phillipines Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of APAC Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Latin America Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Latin America Antisense & RNAI Therapeutics Market share analysis by country, 2022
FIGURE Brazil Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Mexico Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Argentina Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Colombia Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of LATAM Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Middle East and Africa Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Middle East and Africa Antisense & RNAI Therapeutics Market share analysis by country, 2022
FIGURE Saudi Arabia Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE United Arab Emirates Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Israel Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Turkey Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Algeria Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Egypt Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
FIGURE Rest of MEA Antisense & RNAI Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)